• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    More On SAZ.DE

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Stada-Arzneimittel AG (SAZ.DE)

    -XETRA
    44.13 Down 1.28(2.81%) Jun 24, 11:35AM EDT
    ProfileGet Profile for:
    Stada-Arzneimittel AG
    Stadastrasse 2-18
    Bad Vilbel, 61118
    Germany - Map
    Phone: 49 6101 6030
    Fax: 49 6101 603 259
    Website: http://www.stada.de

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drugs - Generic
    Full Time Employees:10,752

    Business Summary 

    STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidine naloxone for pain; Atorvastatin for elevated cholesterol levels; Pantoprazole for stomach ulcer/reflux; Diclofenac for pain/inflammation; and Enalapril for high blood pressure indications. The Branded Products segment offers APO-Go a ParkinsonÂ’s medicine; Aqualor for rhinitis/sore throat; Grippostad a cold medicine; Snup for rhinitis; and Vitaprost for prostate disease indications, as well as Ladival a sun protection product. The company is also involved in the wholesale activities in the pharmaceutical market. It serves patients and/or consumers, doctors, doctorsÂ’ cooperatives, pharmacies, pharmacy cooperatives, hospitals, wholesalers, and other service providers in the health care market, as well as public health insurance organizations or private insurances. The company was founded in 1895 and is headquartered in Bad Vilbel, Germany.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Stada-Arzneimittel AG

    Key Executives 
     PayExercised
    Dr. Matthias Wiedenfels , 43
    Chief Exec. Officer and Member of Exec. Board
    1.13MN/A
    Mr. Helmut Kraft , 57
    Chief Financial Officer and Member of Exec. Board
    1.18MN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in EUR.